Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-4088.84%
operating margin TTM
-7640.98%
revenue TTM
9.46 Million
revenue per share TTM
0.98$
valuation ratios | |
|---|---|
| pe ratio | -1.31 |
| peg ratio | 0.00 |
| price to book ratio | 2.32 |
| price to sales ratio | 54.12 |
| enterprise value multiple | -0.24 |
| price fair value | 2.32 |
profitability ratios | |
|---|---|
| gross profit margin | -20.92% |
| operating profit margin | -7640.98% |
| pretax profit margin | -4088.84% |
| net profit margin | -4088.84% |
| return on assets | -39.87% |
| return on equity | -127.3% |
| return on capital employed | -89.18% |
liquidity ratios | |
|---|---|
| current ratio | 1.65 |
| quick ratio | 1.65 |
| cash ratio | 1.54 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 74.15 |
| days of payables outstanding | 615.26 |
| cash conversion cycle | -541.12 |
| receivables turnover | 4.92 |
| payables turnover | 0.59 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.68 |
| debt equity ratio | 3.04 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.75 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -0.52 |
cash flow ratios | |
|---|---|
| free cash flow per share | -4.42 |
| cash per share | 3.11 |
| operating cash flow per share | -4.40 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -0.52 |
| short term coverage ratios | -3.88 |
| capital expenditure coverage ratio | -193.36 |
Frequently Asked Questions
When was the last time Seres Therapeutics, Inc. (NASDAQ:MCRB) reported earnings?
Seres Therapeutics, Inc. (MCRB) published its most recent earnings results on 05-05-2026.
What is Seres Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Seres Therapeutics, Inc. (NASDAQ:MCRB)'s trailing twelve months ROE is -127.3%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Seres Therapeutics, Inc. (MCRB) currently has a ROA of -39.87%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did MCRB's net profit margin stand at?
MCRB reported a profit margin of -4088.84% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is MCRB's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.65 in the most recent quarter. The quick ratio stood at 1.65, with a Debt/Eq ratio of 3.04.